Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial
Millstine, Denise , Bhagra, Anjali , Jenkins, Sarah M. , Croghan, Ivana T. , Nguyen, Minh-Doan T., Pruthi, Sandhya , Millstine, Denise M, Stan, Daniela L., Pruthi, Sandhya , Stan, Daniela , Boughey, Judy C. , Nguyen, Minh-Doan T.

Mayo Clinic

Integrative Cancer Therapies | September 30, 2019 | Volume: 18 | Issue: No issue available | Pages: No page available

10.1177/1534735419878770 | PMID 31566031 Get It

Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.
Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
Amador, Catalina , Greiner, Timothy C. , Heavican, Tayla B., Smith, Lynette M. , Galvis, Karen, Lone, Waseem , Bouska, Alyssa , d’Amore, Francesco, Pedersen, Martin Bjerregård , Pileri, Stefano , Rosenwald, Andreas , Ott, German , Mottok, Anja , Lim, Soon Thye , Ong, Choon Kiat , Ondrejka, Sarah L. , Song, Joo Y. , Staudt, Louis M. , Weisenburger, Dennis D. , Chan, Wing C. , Iqbal, Javeed , Song, Joo Y , Ong, Choon Kiat , Bouska, Alyssa , Amador, Catalina , Greiner, Timothy C , Smith, Lynette , Pileri, Stefano , d'Amore, Francesco , Iqbal, Javeed , Agostinelli, Claudio , Feldman, Andrew L. , Savage, Kerry J. , Leval, Laurence de , Gaulard, Philippe , Campo, Elı́as , Jaffe, Elaine S. , Rimsza, Lisa M. , Vose, Julie M. , Lone, Waseem G

Mayo Clinic

Blood | September 27, 2019 | Volume: 134 | Issue: 24 | Pages: 2159-2170

10.1182/blood.2019000779 | PMID 31562134 Get It

One-third of peripheral T-cell lymphomas are “not otherwise specified” (PTCL-NOS), but they have been subdivided into 2 subgroups based on gene expression profiling. Amador and colleagues generated an immunohistochemical algorithm that parallels the molecular separation of PTCL-NOS and provides useful prognostic information.
Top Ten Tips Palliative Care Clinicians Should Know About Physical Medicine and Rehabilitation
Brassil, Michelle E., Zheng, Jasmine , Smith, Sean R. , Tolchin, Dorothy W. , Wittry, Sarah A. , Jones, Christopher A. , Chernack, Betty, Cheville, Andrea , Jones, C. P.

Mayo Clinic

Journal of Palliative Medicine | September 26, 2019 | Volume: 23 | Issue: 1 | Pages: 129-135

10.1089/jpm.2019.0440 | PMID 31556786 Get It

Physical medicine and rehabilitation (PM&R) is a specialty of medicine focused on optimizing function and quality of life for individuals with physical impairments, injuries, or disabling illnesses. Given the sometimes acute nature of the loss of function and even loss of independence, there are significant palliative care (PC) needs within patients seen by PM&R. This article, written by a team of PM&R and PC specialists, aims to help the PC team better understand the world of postacute care, expand their toolkit for treating musculoskeletal and neurological symptoms, improve prognostication for patients with brain and spinal cord injuries, and decide when patients may benefit from PM&R consultation and support. There is significant overlap between the populations treated by PM&R and PC. Better integration between these specialties will help patients to maintain independence as well as advance excellent patient-centered care.
Assessment of Macroprolactin Persistence in a Large Clinical Population
Delaney, Sarah , Bornhorst, Joshua A. , Bornhorst, Joshua , Delaney, Sarah, Algeciras‐Schimnich, Alicia

Mayo Clinic

American Journal of Clinical Pathology | September 11, 2019 | Volume: 152 | Issue: Supplement_1 | Pages: S12-S12

10.1093/ajcp/aqz112.023 Get It

Abstract Background Pathologic causes of hyperprolactinemia include prolactin-secreting pituitary adenoma (prolactinoma), diseases of the hypothalamus, primary hypothyroidism, and renal failure. Another cause of hyperprolactinemia is the presence of macroprolactin, a high-molecular-mass complex of prolactin and immunoglobulins, which constitutes a biologically inactive form of prolactin. Detection of macroprolactin is important to avoid misdiagnosis and inappropriate treatment; however, relatively little is known about the persistence of macroprolactin in patients over time or how macroprolactin concentrations evolve within patients. The objective of this study was to examine the changes in macroprolactin and prolactin over time in a large clinical population. Methods All physician-ordered macroprolactin tests from December 2011 to October 2018 (n = 5,318 unique patients) were examined. Data were extracted from patients with repeat collections (≥2 timepoints) during this 7-year period (n = 269). Macroprolactin testing was performed using the Roche Elecsys Prolactin II assay. Prior to analysis, an equal volume of 25% polyethylene glycol (PEG) was added to patient serum, causing macroprolactin to precipitate. Following centrifugation, unprecipitated prolactin was measured in the supernatant, as well as an aliquot of the native sample (measuring total prolactin). Macroprolactin (precipitated prolactin) was calculated by subtracting the unprecipitated prolactin from the total prolactin concentration. For this study, a specimen was considered positive for macroprolactin if the percentage of precipitated prolactin was ≥60%. Results A total of 14% (37/269) of patients tested positive for macroprolactin in at least one of the sequential determinations. For all patients with two or more timepoints, the mean interdetermination change in percent macroprolactin was +0.6% and the mean interdetermination change in total prolactin was –11.6 ng/mL. The mean time between determinations in these patients was 303 days. For the 37 patients that had a positive macroprolactin determination, 25 remained positive across all sample collections (mean interdetermination change of +0.5% macroprolactin, mean interdetermination change in total prolactin of +0.4 ng/mL), seven samples went from positive to negative (mean interdetermination change of –10% macroprolactin, mean change in total prolactin of +0.2 ng/mL), and two samples went from negative to positive (mean interdetermination change of +5.5% macroprolactin, mean change in total prolactin of +1.3 ng/mL). The remaining 3 of the 37 specimens had more than two determinations that fluctuated above and below the predefined cutoff. Conclusions The results from this study suggest that the presence of macroprolactin largely but not exclusively persists over time. Additionally, macroprolactin rarely appears after a previously negative assessment (2/235 patients). Furthermore, only small increases in sequential percent macroprolactin determinations were observed in this data set. The prevalence of the persistence of macroprolactin protein over time might have important implications for patient prolactin monitoring.
Interventions for uterine fibroids: an overview of Cochrane Reviews
Brito, Luiz Gustavo Oliveira , Chaim, Sarah O Olivi, Stewart, Elizabeth A. , Chaim, Sarah Olivi, Martins, Wellington P. , Farquhar, Cindy M. , Brito, Luiz Gustavo Oliveira

Mayo Clinic

Cochrane Database of Systematic Reviews | September 11, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/14651858.cd013426 Get It

Dominant collagen XII mutations cause a distal myopathy
Mohassel, Payam , Liewluck, Teerin , Hu, Ying , Ezzo, Daniel, Ogata, Tracy, Saade, Dimah , Neuhaus, Sarah , Bolduc, Véronique , Zou, Yaqun , Donkervoort, Sandra , Medne, Līvija , Sumner, Charlotte J. , Dyck, P. James B. , Wierenga, Klaas J. , Tennekoon, Gihan, Chen, Jiani , Winder, Thomas , Staff, Nathan P. , Foley, A. Reghan , Koch, Manuel , Bönnemann, Carsten G. , Liewluck, T , Staff, Nathan P , Finkel, Richard S. , Winder, Thomas L., Donkervoort, Sandra

Mayo Clinic

Annals of Clinical and Translational Neurology | September 11, 2019 | Volume: 6 | Issue: 10 | Pages: 1980-1988

10.1002/acn3.50882 | PMID 31509352 Get It

AbstractObjectiveTo characterize the natural history and clinical features of myopathies caused by mono‐allelic, dominantly acting pathogenic variants in COL12A1.MethodsPatients with dominant COL12A1‐related myopathies were characterized by history and clinical examination, muscle imaging, and genetic analysis. Pathogenicity of the variants was assessed by immunostaining patient‐derived dermal fibroblast cultures for collagen XII.ResultsFour independent families with childhood‐onset weakness due to novel, dominantly acting pathogenic variants in COL12A1 were identified. Adult patients exhibited distal‐predominant weakness. Three families carried dominantly acting glycine missense variants, and one family had a heterozygous, intragenic, in‐frame deletion of exon 52 of COL12A1. All pathogenic variants resulted in increased intracellular retention of collagen XII in patient‐derived fibroblasts as well as loss of extracellular, fibrillar collagen XII deposition. Since haploinsufficiency for COL12A1 is largely clinically asymptomatic, we designed and evaluated small interfering RNAs (siRNAs) that specifically target the mutant allele containing the exon 52 deletion. Immunostaining of the patient fibroblasts treated with the siRNA showed a near complete correction of collagen XII staining patterns.InterpretationThis study characterizes a distal myopathy phenotype in adults with dominant COL12A1 pathogenic variants, further defining the phenotypic spectrum and natural history of COL12A1‐related myopathies. This work also provides proof of concept of a precision medicine treatment approach by proposing and validating allele‐specific knockdown using siRNAs specifically designed to target a patient’s dominant COL12A1 disease allele.
Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program
VanderPluym, Juliana H. , Hamilton, Katherine , Hindiyeh, Nada , Robbins, Matthew S. , Starling, Amaal J. , Vargas, Bert B., Gibbons, Sarah K., Vgontzas, Angeliki , Robbins, Matthew S , Gibbons, Sarah K., VanderPluym, Juliana

Mayo Clinic

Headache: The Journal of Head and Face Pain | September 11, 2019 | Volume: 59 | Issue: 9 | Pages: 1656-1658

10.1111/head.13649 | PMID 31508808 Get It

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines
Crow, Lauren , Jambusaria‐Pahlajani, Anokhi , Chung, Christina Lee , Baran, David A. , Lowenstein, Stefan E. , Abdelmalek, Mark, Ahmed, Rehana L. , Anadkat, Milan J. , Arcasoy, Selim M. , Berg, Daniel , Bibee, Kristin , Billingsley, Elizabeth M. , Black, William H., Blalock, Travis W. , Bleicher, Melissa, Brennan, Daniel C. , Brodland, David G., Brown, Mariah , Carroll, Bryan T. , Carucci, John A. , Chang, Timothy W., Chaux, George, Cusack, Carrie Ann, Dilling, Daniel F. , Doyle, Alden , Emtiazjoo, Amir , Ferguson, Nkanyezi H., Fosko, Scott W. , Fox, Matthew C., Göral, Simin , Gray, Alice , Griffin, John R., Hall, Shelley , Hanlon, Allison , Hayes, Don , Hickey, Gavin , Holtz, Jonathan E., Hopkins, R. Samuel, Hu, Jenny, Huang, Conway C. , Kapnadak, Siddhartha G. , Kraus, Edward S., Leitenberger, Justin J. , Lim, Mary Ann , Longo, María Isabel , Malik, Shahid M. , Menter, Alan , Myers, Sarah A., Neuburg, Marcy, Nijhawan, Rajiv I. , Norman, Douglas J., Otley, Clark C. , Paek, So Yeon , Parulekar, Amit , Patel, Manisha J., Patton, Timothy , Pugliano‐Mauro, Melissa , Ranganna, Karthik, Redenius, Rachel, Samie, Faramarz H. , Shin, Thuzar M. , Singer, Jonathan P. , Singh, Pooja , Soon, Seaver L. , Squires, Ronald A., Stasko, Thomas, Stein, Jennifer , Taler, Sandra J. , Thomas, Christie P. , Tokman, Sofya , Tomic, Rade , Twigg, Amanda R. , Wigger, M., Zeitouni, Nathalie C., Crow, Lauren D , Leca, Nicolae , Mallea, Jorge M. , Tomic, Rade , Singer, Jonathan P , Baran, David A , Paek, So Yeon , Ferguson, Nkanyezi , Hachem, Ramsey R. , Jiang, Shang I. Brian , Lease, Erika D. , Lee, James , Patel, Vishal Anil , Ravichandran, Ashwin Kumar , Redenius, Rachel A., Roll, Garrett Richard , Soriano, Teresa T. , Terrault, Norah A. , Arron, Sarah T. , Thomas, Christie P

Mayo Clinic

Transplant International | September 10, 2019 | Volume: 32 | Issue: 12 | Pages: 1268-1276

10.1111/tri.13520 | PMID 31502728 Get It

Identifying Opportunities for Advancing Weight Management in Primary Care
Croghan, Ivana T. , Ebbert, Jon O. , Njeru, Jane W. , Rajjo, Tamim , Lynch, Brian , DeJesus, Ramona S. , Jensen, Michael D. , Kaufman, Tara K. , Schroeder, Darrell R. , Crane, Sarah J. , Tulledge‐Scheitel, Sidna M. , Rajjo, Tamim I, Lynch, Brian A , Phelan, Sean, Tulledge-Scheitel, Sidna M, Schroeder, Darrell , Fischer, Karen M. , Phelan, Sean M. , Rutten, Lila J. Finney

Mayo Clinic

Journal of Primary Care & Community Health | September 9, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2150132719870879 | PMID 31496342 Get It

Objective: Much has been written about the patients’ perspective concerning weight management in health care. The purpose of this survey study was to assess perspectives of primary care providers (PCPs) and nurses toward patient weight management and identify possible areas of growth. Patients and Methods: We emailed a weight management–focused survey to 674 eligible participants (437 [64.8%] nurses and 237 [35.2%] PCPs) located in 5 outpatient primary care clinics. The survey focused on opportunities, practices, knowledge, confidence, attitudes, and beliefs. A total of 219 surveys were returned (137 [62.6%] from nurses and 82 [34.4%] from PCPs). Results: Among 219 responders, 85.8% were female and 93.6% were white non-Hispanic. In this study, PCPs and nurses believed obesity to be a major health problem. While PCPs felt more equipped than nurses to address weight management ( P < .001) and reported receiving more training than nurses (50.0% vs 17.6%, respectively), both felt the need for more training on obesity (73.8% and 79.4%, respectively). Although, PCPs also spent more patient contact time providing weight management services versus nurses ( P < .001), the opportunity/practices score was lower for PCPs than nurses (−0.35 ± 0.44 vs −0.17 ± 0.41, P < .001) with PCPs more likely to say they lacked the time to discuss weight and they worried it would cause a poor patient-PCP relationship. The knowledge/confidence score also differed significantly between the groups, with nurses feeling less equipped to deal with weight management issues than PCPs (−0.42 ± 0.43 vs −0.03 ± 0.55, P < .001). Neither group seemed very confident, with those in the PCP group only answering with an average score of neutral. Conclusion: By asking nurses and PCP general questions about experiences, attitudes, knowledge, and opinions concerning weight management in clinical care, this survey has identified areas for growth in obesity management. Both PCPs and nurses would benefit from additional educational training on weight management.
Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Arain, Mustafa A., Chen, Yi‐Jen , Ciombor, Kristen K. , Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Hoffe, Sarah E. , Hunt, Steven R., Kamel, Ahmed, Kirilcuk, Natalie, Krishnamurthi, Smitha , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Miller, Eric D. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Parikh, Aparna, Patel, Hitendra , Pedersen, Katrina S. , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Willett, Christopher G. , Johnson-Chilla, Alyse, Gregory, Kristina M., Gurski, Lisa A., Hubbard, Joleen, Miller, Eric D. , Meyerhardt, Jeffrey A , Pedersen, Katrina , Venook, Alan P. , Cohen, Stacey A. , Hubbard, Joleen M. , Patel, Hitendra, Saltz, Leonard B. , Schneider, Charles John , Stoffel, Elena M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | September 5, 2019 | Volume: 17 | Issue: 9 | Pages: 1109-1133

10.6004/jnccn.2019.0043 | PMID 31487687 Get It

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.